Clifutinib Food Effect Study in Healthy Subjects

Clinical trial NCT05454098 · COMPLETED

Trial details

NCT number: NCT05454098
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia in Children

Start date: 2022-11-08
Primary completion: 2022-12-08
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.